Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
American Journal of Speech-Language Pathology|May 16, 2019
Perceived Gaps in Genetics Training Among Audiologists and Speech-Language Pathologists: Lessons From a National SurveyBeate Peter, Michael J Dougherty, E Kate Reed, et al.
Journal of Genetic Counseling|October 25, 2023
Microlearning: Evidence-based education that is effective for busy professionals and short attention spansTherese Ingram Nissen, Emily A Edelman, Linda Steinmark, et al.
The Pediatric Infectious Disease Journal|June 9, 2016
Limited Evidence on the Management of Respiratory Tract Infections in Down's Syndrome: A Systematic ReviewLogan Manikam, Kate Reed, Roderick P Venekamp, et al.
BMC Pregnancy and Childbirth|October 12, 2016
Exploring the third delay: an audit evaluating obstetric triage at Mulago National Referral HospitalJennifer Forshaw, Stephanie Raybould, Emilie Lewis, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 20, 2017
Characterization of pulmonary arteriovenous malformations in ACVRL1 versus ENG mutation carriers in hereditary hemorrhagic telangiectasiaWeiyi Mu, Zachary A Cordner, Kevin Yuqi Wang, et al.
Journal of Genetic Counseling|October 18, 2023
A team-based approach to cardiogenomic educationEmily A Edelman, Kalisi Logan, Therese Ingram Nissen, et al.
Biochemical and Biophysical Research Communications|November 10, 2006
Functionality of NGF-protected PC12 cells following exposure to 6-hydroxydopamineEdel T Kavanagh, John P Loughlin, Kate Reed Herbert, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|January 9, 2026
Defining palliative care service capability: a scoping review to support quality improvement and benchmarkingSabina Clapham, Barbara Daveson, Animut Alebel Ayalew, et al.
Patient Education and Counseling|July 22, 2020
Differences in cancer patients' and clinicians' preferences for disclosure of uncertain genomic tumor testing resultsAnny T Fenton, Eric C Anderson, Elizabeth Scharnetzki, et al.
Cancer|October 22, 2008
A multicenter phase 2 study of risk-adjusted salvage chemotherapy incorporating vinorelbine and gemcitabine for relapsed and refractory lymphomaSant-Rayn Pasricha, Andrew Grigg, John Catalano, et al.
Pageof 5